Quantum Cyber director granted 112,859 stock options
Quantum Cyber N.V. director Peter O'Rourke received a grant of stock options described as a "Stock Option (Right to Buy)." The award covers 112,859 options, each exercisable for one ordinary share at an exercise price of $1.45 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Quantum Cyber N.V. director Peter O'Rourke received a grant of stock options described as a "Stock Option (Right to Buy)." The award covers 112,859 options, each exercisable for one ordinary share at an exercise price of $1.45 per share.
The options were granted on July 6, 2026 and are scheduled to expire on July 6, 2036. The filing shows O'Rourke holding a total of 112,859 derivative securities of this type directly following the grant, indicating a compensation-related award rather than an open-market purchase or sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 112,859 | $0.00 | $0.00 |
Key Figures
Key Terms
Stock Option (Right to Buy) financial
Grant, award, or other acquisition financial
derivative securities financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Quantum Cyber N.V. (QUCY) report for Peter O'Rourke?
How many Quantum Cyber (QUCY) options were granted to Peter O'Rourke and at what price?
When do Peter O'Rourke’s Quantum Cyber (QUCY) stock options expire?
Is Peter O'Rourke’s Quantum Cyber (QUCY) Form 4 transaction a market buy or sell?
What is Peter O'Rourke’s Quantum Cyber (QUCY) derivative position after the option grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.